A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Industry Licensing Information Bookmark and Share

Partner with City of Hope

City of Hope’s primary interest is caring for and healing our patients.  To accomplish this goal, our researchers and clinicians are continuing to push the science of medicine forward. The Office of Technology Licensing assists in this process by facilitating partnerships with companies whose resources and commercial expertise help translate these basic discoveries into commercial products so they may one day be available to the public and improve the health and prosperity of our patients.

Below is a brief overview of some facts and statistics about City of Hope:
 
  • National Cancer Institute-designated comprehensive cancer center; ranked as a best cancer hospital by U.S.News & World Report
     
  • Translationally focused research institute with core areas of research in oncology, HIV/AIDS and diabetes
     
  • 38 active and 9 pending City of Hope investigational new drugs with the Food and Drug Administration
     
  • 300 ongoing clinical trials
     
  • 100 principal investigators
     
  • $323 million in research grants and royalties

Please contact the OTL team to inquire further about any available technologies or to simply learn more about City of Hope.
 

Featured Technology

 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices. Learn more.
 
 
Previously Featured Technology
 
 
Licensing Opportunities
 
City of Hope has developed a range of new technologies many of which are available for licensing to established or startup companies.  Almost all of City of Hope's new technologies fall within the fields of Biotechnology, Pharmaceuticals, Diagnostics or Medical Devices.
 
Please browse the available technologies below:
 
 

Industry Licensing Information

Partner with City of Hope

City of Hope’s primary interest is caring for and healing our patients.  To accomplish this goal, our researchers and clinicians are continuing to push the science of medicine forward. The Office of Technology Licensing assists in this process by facilitating partnerships with companies whose resources and commercial expertise help translate these basic discoveries into commercial products so they may one day be available to the public and improve the health and prosperity of our patients.

Below is a brief overview of some facts and statistics about City of Hope:
 
  • National Cancer Institute-designated comprehensive cancer center; ranked as a best cancer hospital by U.S.News & World Report
     
  • Translationally focused research institute with core areas of research in oncology, HIV/AIDS and diabetes
     
  • 38 active and 9 pending City of Hope investigational new drugs with the Food and Drug Administration
     
  • 300 ongoing clinical trials
     
  • 100 principal investigators
     
  • $323 million in research grants and royalties

Please contact the OTL team to inquire further about any available technologies or to simply learn more about City of Hope.
 

Featured Technology

Featured Technology

 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices. Learn more.
 
 
Previously Featured Technology
 
 
Licensing Opportunities
 
City of Hope has developed a range of new technologies many of which are available for licensing to established or startup companies.  Almost all of City of Hope's new technologies fall within the fields of Biotechnology, Pharmaceuticals, Diagnostics or Medical Devices.
 
Please browse the available technologies below:
 
 

Antibodies

Anti-Virals and Vaccines

Cell Base Therapies

Diagnostics

Disease Models

Gene Therapies

Medical Devices

Peptides and Aptamers

siRNA

Small Molecules

Overview
Office of Technology Licensing
City of Hope
1500 E. Duarte Rd.
Modular 101
Duarte, CA 91010
 
 
 
Center for Applied Technology Development (CATD)
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

City of Hope Campus Map
 
 
 
 
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • The outlook and length of survival has not changed much in the past 25 years for patients suffering from an aggressive form of pancreatic cancer known as pancreatic ductal adenocarcinoma (PDAC). These patients still have few options for therapy; currently available therapies are generally toxic and do not incre...
  • “With bladder cancer, the majority of patients that I see can be cured,” said urologist Kevin Chan, M.D., head of reconstructive urology at City of Hope. “The challenge is to get patients the same quality of life that they had before surgery.” To meet this challenge, Chan and the urologic team at City of Hope [...
  • Already pioneers in the use of immunotherapy, City of Hope researchers are now testing the bold approach to cancer treatment against one of medicine’s biggest challenges: brain cancer. This month, they will launch a clinical trial using patients’ own modified T cells to fight advanced brain tumors. One of but a...
  • Brain cancer may be one of the most-frightening diagnoses people can receive, striking at the very center of who we are as individuals. Further, it often develops over time, causing no symptoms until it’s already advanced. Listen to City of Hope Radio as Behnam Badie, M.D., director of the Brain Tumor Pro...
  • The whole is greater than the sum of its parts. It takes a village. No man is an island. Choose your aphorism: It’s a simple truth that collaboration usually is better than isolation. That’s especially true when you’re trying to introduce healthful habits and deliver health care to people at risk of disease and...
  • When Maryland Governor Larry Hogan announced earlier this week that he has the most common form of non-Hodgkin lymphoma, he was giving voice to the experience of more than 71,000 Americans each year. The announcement came with Hogan’s promise to stay in office while undergoing aggressive treatment for the...
  • The spine can be affected by many different kinds of tumors. Malignant, or cancerous, tumors can arise within the spine itself. Secondary spinal tumors, which are actually much more common, begin as cancers in another part of the body, such as the breast and prostate, and then spread, or metastasize, to the spi...
  • Although most cancer occurs in older adults, the bulk of cancer research doesn’t focus on this vulnerable and fast-growing population. City of Hope and its Cancer and Aging Research Team aim to change that, and they’re getting a significant boost from Professional Practice Leader Peggy Burhenn, R.N....
  • Liz Graef-Larcher’s first brain tumor was discovered by accident six years ago. The then-48-year-old with a long history of sinus problems and headaches had been sent for an MRI, and the scan found a lesion in her brain called a meningioma – a tumor that arises in the meninges, the layers of tissue that cover a...
  • The colon and rectum are parts of the body’s gastrointestinal system, also called the digestive tract. After food is digested in the stomach and nutrients are absorbed in the small intestine, the remaining material moves down into the lower large intestine (colon) where water and nutrients are absorbed. The low...
  • If there is one truism about hospital stays it is that patients want to get out. For many, however, the joy of being discharged is tempered by the unexpected challenges that recovery in a new setting may pose. Even with professional help, the quality of care and treatment that patients receive at City of Hope [...
  • Jana Portnow, M.D., associate director of the Brain Tumor Program at City of Hope, didn’t expect to specialize in treating brain tumors. But, early in her career, she undertook a year of research on pain management and palliative care and, in that program, got to know many patients with brain tumors. After that...
  • Ask any patient: Nurses are as pivotal in their care as doctors. They answer the call of a patient in the middle of the night, they hold the patient’s hand as he or she takes on yet another round of treatment and, in the best-case scenario, they wave goodbye as the patient leaves the hospital, […]
  • Many oncologists, not to mention their patients, might think that there’s no place for mathematical analysis in the treatment of cancer. They might think that all treatment decisions are based on unique factors affecting individual patients, with no connection to other patients and their treatment regimen...
  • Within three days in 2007, Stephanie Hosford, then 37, learned that she was pregnant with her long-awaited second child – and that she had triple-negative breast cancer. Soon afterward, Hosford discovered that she and her husband, Grant, had been approved to adopt a little girl from China.  After encountering m...